|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 458 for Pdcd1

<< First    < Previous  |  Next >    Last >>
0.031s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
33419761 | J:305678
First Author: Dovedi SJ
Year: 2021
Journal: Cancer Discov
Title: Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells.
Volume: 11
Issue: 5
Pages: 1100-1117
•
•
•
•
•
Publication
33117369 | J:314544
 
First Author: Han JH
Year: 2020
Journal: Front Immunol
Title: Effective Anti-tumor Response by TIGIT Blockade Associated With FcγR Engagement and Myeloid Cell Activation.
Volume: 11
Pages: 573405
•
•
•
•
•
Publication
38377992 | J:347152
First Author: He C
Year: 2024
Journal: Mol Cell
Title: UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity.
Volume: 84
Issue: 6
Pages: 1120-1138.e8
•
•
•
•
•
Publication
15484188 | J:94604
First Author: Oflazoglu E
Year: 2004
Journal: Eur J Immunol
Title: Paradoxical role of programmed death-1 ligand 2 in Th2 immune responses in vitro and in a mouse asthma model in vivo.
Volume: 34
Issue: 12
Pages: 3326-36
•
•
•
•
•
Publication
15685176 | J:96369
First Author: Probst HC
Year: 2005
Journal: Nat Immunol
Title: Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4.
Volume: 6
Issue: 3
Pages: 280-6
•
•
•
•
•
Publication
15827960 | J:97795
First Author: Augello A
Year: 2005
Journal: Eur J Immunol
Title: Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.
Volume: 35
Issue: 5
Pages: 1482-90
•
•
•
•
•
Publication
17116737 | J:124584
First Author: Fife BT
Year: 2006
Journal: J Exp Med
Title: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
Volume: 203
Issue: 12
Pages: 2737-47
•
•
•
•
•
Publication
18981087 | J:140951
First Author: Chang WS
Year: 2008
Journal: J Immunol
Title: Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.
Volume: 181
Issue: 10
Pages: 6707-10
•
•
•
•
•
Publication
19201863 | J:144794
First Author: Reynoso ED
Year: 2009
Journal: J Immunol
Title: Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.
Volume: 182
Issue: 4
Pages: 2102-12
•
•
•
•
•
Publication
20007574 | J:157462
First Author: Currie AJ
Year: 2009
Journal: J Immunol
Title: Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
Volume: 183
Issue: 12
Pages: 7898-908
•
•
•
•
•
Publication
19783989 | J:157748
First Author: Fife BT
Year: 2009
Journal: Nat Immunol
Title: Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal.
Volume: 10
Issue: 11
Pages: 1185-92
•
•
•
•
•
Publication
19949087 | J:159034
First Author: Frank GM
Year: 2010
Journal: J Immunol
Title: Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of Herpes Simplex Virus 1 latency.
Volume: 184
Issue: 1
Pages: 277-86
•
•
•
•
•
Publication
20679213 | J:163588
First Author: Jin HT
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection.
Volume: 107
Issue: 33
Pages: 14733-8
•
•
•
•
•
Publication
22319445 | J:195403
First Author: Hafalla JC
Year: 2012
Journal: PLoS Pathog
Title: The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.
Volume: 8
Issue: 2
Pages: e1002504
•
•
•
•
•
Publication
23888055 | J:203537
First Author: Gao X
Year: 2013
Journal: J Biol Chem
Title: Splice isoforms of phosducin-like protein control the expression of heterotrimeric G proteins.
Volume: 288
Issue: 36
Pages: 25760-8
•
•
•
•
•
Publication
28270509 | J:242504
First Author: Li K
Year: 2017
Journal: J Biol Chem
Title: In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network.
Volume: 292
Issue: 16
Pages: 6799-6809
•
•
•
•
•
Publication
30709740 | J:285835
First Author: Zhou J
Year: 2019
Journal: Immunity
Title: Liver-Resident NK Cells Control Antiviral Activity of Hepatic T Cells via the PD-1-PD-L1 Axis.
Volume: 50
Issue: 2
Pages: 403-417.e4
•
•
•
•
•
Publication
32602900 | J:299176
First Author: Narayanapillai SC
Year: 2020
Journal: Carcinogenesis
Title: Modulation of the PD-1/PD-L1 immune checkpoint axis during inflammation-associated lung tumorigenesis.
Volume: 41
Issue: 11
Pages: 1518-1528
•
•
•
•
•
Publication
26318293 | J:315419
First Author: Huang RY
Year: 2015
Journal: Oncotarget
Title: LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.
Volume: 6
Issue: 29
Pages: 27359-77
•
•
•
•
•
Publication
26378076 | J:328700
First Author: Herold M
Year: 2015
Journal: J Immunol
Title: B7-H1 Selectively Controls TH17 Differentiation and Central Nervous System Autoimmunity via a Novel Non-PD-1-Mediated Pathway.
Volume: 195
Issue: 8
Pages: 3584-95
•
•
•
•
•
Publication
29018057 | J:320234
First Author: Wang J
Year: 2017
Journal: Cancer Prev Res (Phila)
Title: PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions.
Volume: 10
Issue: 12
Pages: 684-693
•
•
•
•
•
Publication
36323784 | J:340011
First Author: Wang TW
Year: 2022
Journal: Nature
Title: Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Volume: 611
Issue: 7935
Pages: 358-364
•
•
•
•
•
Publication
18641123 | J:139033
First Author: Lázár-Molnár E
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2.
Volume: 105
Issue: 30
Pages: 10483-8
•
•
•
•
•
Publication
10485649 | J:78802
First Author: Nishimura H
Year: 1999
Journal: Immunity
Title: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.
Volume: 11
Issue: 2
Pages: 141-51
•
•
•
•
•
Publication
22641383 | J:189115
First Author: Yokosuka T
Year: 2012
Journal: J Exp Med
Title: Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2.
Volume: 209
Issue: 6
Pages: 1201-17
•
•
•
•
•
Publication
21768399 | J:179154
First Author: Flies DB
Year: 2011
Journal: J Immunol
Title: Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models.
Volume: 187
Issue: 4
Pages: 1537-41
•
•
•
•
•
Publication
20410257 | J:160315
First Author: Wang J
Year: 2010
Journal: Int Immunol
Title: PD-1 deficiency results in the development of fatal myocarditis in MRL mice.
Volume: 22
Issue: 6
Pages: 443-52
•
•
•
•
•
Publication
27244558 | J:245926
First Author: Sakai S
Year: 2016
Journal: PLoS Pathog
Title: CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease.
Volume: 12
Issue: 5
Pages: e1005667
•
•
•
•
•
Publication
19302141 | J:152436
First Author: Wang C
Year: 2009
Journal: Immunology
Title: Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1.
Volume: 126
Issue: 3
Pages: 329-35
•
•
•
•
•
Publication
22432050 | J:207275
 
First Author: Sugino Y
Year: 2012
Journal: Sci Rep
Title: BALB/c-Fcgr2bPdcd1 mouse expressing anti-urothelial antibody is a novel model of autoimmune cystitis.
Volume: 2
Pages: 317
•
•
•
•
•
Publication
16352741 | J:118829
First Author: Okazaki T
Year: 2005
Journal: J Exp Med
Title: Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b-/-Pdcd1-/- mice.
Volume: 202
Issue: 12
Pages: 1643-8
•
•
•
•
•
Publication
23883516 | J:205310
First Author: Licata LA
Year: 2013
Journal: J Leukoc Biol
Title: Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.
Volume: 94
Issue: 4
Pages: 813-23
•
•
•
•
•
Publication
30333312 | J:291022
 
First Author: Ordikhani F
Year: 2018
Journal: JCI Insight
Title: Targeting antigen-presenting cells by anti-PD-1 nanoparticles augments antitumor immunity.
Volume: 3
Issue: 20
•
•
•
•
•
Publication
29337311 | J:258822
First Author: Hossain DMS
Year: 2018
Journal: J Clin Invest
Title: Dinaciclib induces immunogenic cell death and enhances anti-PD1-mediated tumor suppression.
Volume: 128
Issue: 2
Pages: 644-654
•
•
•
•
•
Publication
24319287 | J:211871
First Author: Park SJ
Year: 2014
Journal: J Leukoc Biol
Title: Negative role of inducible PD-1 on survival of activated dendritic cells.
Volume: 95
Issue: 4
Pages: 621-9
•
•
•
•
•
Publication
19299723 | J:147123
First Author: Fuse S
Year: 2009
Journal: J Immunol
Title: Recall responses by helpless memory CD8+ T cells are restricted by the up-regulation of PD-1.
Volume: 182
Issue: 7
Pages: 4244-54
•
•
•
•
•
Publication
32134744 | J:329656
First Author: Judge SJ
Year: 2020
Journal: J Clin Invest
Title: Minimal PD-1 expression in mouse and human NK cells under diverse conditions.
Volume: 130
Issue: 6
Pages: 3051-3068
•
•
•
•
•
Publication
37280233 | J:347123
First Author: Nishi W
Year: 2023
Journal: Nat Commun
Title: Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters.
Volume: 14
Issue: 1
Pages: 3157
•
•
•
•
•
Publication
18651994 | J:141990
First Author: Kido M
Year: 2008
Journal: Gastroenterology
Title: Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling.
Volume: 135
Issue: 4
Pages: 1333-43
•
•
•
•
•
Publication
24043779 | J:201138
First Author: Rui Y
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response.
Volume: 110
Issue: 40
Pages: 16073-8
•
•
•
•
•
Publication
21469086 | J:176637
First Author: Iliopoulos D
Year: 2011
Journal: Eur J Immunol
Title: The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21.
Volume: 41
Issue: 6
Pages: 1754-63
•
•
•
•
•
Publication
20453843 | J:160698
First Author: Good-Jacobson KL
Year: 2010
Journal: Nat Immunol
Title: PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.
Volume: 11
Issue: 6
Pages: 535-42
•
•
•
•
•
Publication
25464856 | J:323792
First Author: Staron MM
Year: 2014
Journal: Immunity
Title: The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection.
Volume: 41
Issue: 5
Pages: 802-14
•
•
•
•
•
Publication
37379210 | J:338372
First Author: Wu Z
Year: 2023
Journal: Cell Rep
Title: Coupled deglycosylation-ubiquitination cascade in regulating PD-1 degradation by MDM2.
Volume: 42
Issue: 7
Pages: 112693
•
•
•
•
•
Publication
21623380 | J:174315
First Author: Kao C
Year: 2011
Journal: Nat Immunol
Title: Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection.
Volume: 12
Issue: 7
Pages: 663-71
•
•
•
•
•
Publication
23545706 | J:208973
First Author: Pauken KE
Year: 2013
Journal: Diabetes
Title: PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
Volume: 62
Issue: 8
Pages: 2859-69
•
•
•
•
•
Publication
33045061 | J:307777
 
First Author: Tan CL
Year: 2021
Journal: J Exp Med
Title: PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.
Volume: 218
Issue: 1
•
•
•
•
•
Publication
25624454 | J:281892
First Author: McKay JT
Year: 2015
Journal: J Immunol
Title: PD-1 suppresses protective immunity to Streptococcus pneumoniae through a B cell-intrinsic mechanism.
Volume: 194
Issue: 5
Pages: 2289-99
•
•
•
•
•
Publication
28768724 | J:250823
First Author: McKay JT
Year: 2017
Journal: J Immunol
Title: PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.
Volume: 199
Issue: 6
Pages: 2020-2029
•
•
•
•
•
Publication
25964334 | J:222944
First Author: Liu J
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Volume: 112
Issue: 21
Pages: 6682-7
•
•
•
•
•
Publication
24165808 | J:208723
First Author: McBerry C
Year: 2014
Journal: Eur J Immunol
Title: PD-1 modulates steady-state and infection-induced IL-10 production in vivo.
Volume: 44
Issue: 2
Pages: 469-79
•
•
•
•
•
Publication
27533014 | J:254630
First Author: Karunarathne DS
Year: 2016
Journal: Immunity
Title: Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
Volume: 45
Issue: 2
Pages: 333-45
•
•
•
•
•
Publication
29617671 | J:271069
First Author: Rota G
Year: 2018
Journal: Cell Rep
Title: Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo.
Volume: 23
Issue: 1
Pages: 39-49
•
•
•
•
•
Publication
27410049 | J:234397
First Author: Zhang B
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model.
Volume: 113
Issue: 30
Pages: 8490-5
•
•
•
•
•
Publication
25641586 | J:223837
First Author: Zhang J
Year: 2015
Journal: Eur J Immunol
Title: Micro-RNA-155-mediated control of heme oxygenase 1 (HO-1) is required for restoring adaptively tolerant CD4+ T-cell function in rodents.
Volume: 45
Issue: 3
Pages: 829-42
•
•
•
•
•
Publication
38176655 | J:352102
First Author: Eddens T
Year: 2024
Journal: Mucosal Immunol
Title: PD-1 signaling in neonates restrains CD8(+) T cell function and protects against respiratory viral immunopathology.
Volume: 17
Issue: 3
Pages: 476-490
•
•
•
•
•
Publication
34531874 | J:311189
 
First Author: Howard E
Year: 2021
Journal: Front Immunol
Title: PD-1 Blockade on Tumor Microenvironment-Resident ILC2s Promotes TNF-α Production and Restricts Progression of Metastatic Melanoma.
Volume: 12
Pages: 733136
•
•
•
•
•
Publication
19553535 | J:151401
First Author: Hagenow K
Year: 2009
Journal: J Immunol
Title: Ncf1-associated reduced oxidative burst promotes IL-33R+ T cell-mediated adjuvant-free arthritis in mice.
Volume: 183
Issue: 2
Pages: 874-81
•
•
•
•
•
Publication
25404361 | J:230706
First Author: Jaworska K
Year: 2015
Journal: J Immunol
Title: Both PD-1 ligands protect the kidney from ischemia reperfusion injury.
Volume: 194
Issue: 1
Pages: 325-33
•
•
•
•
•
Publication
32610128 | J:300868
First Author: Pauken KE
Year: 2020
Journal: Cell Rep
Title: The PD-1 Pathway Regulates Development and Function of Memory CD8+ T Cells following Respiratory Viral Infection.
Volume: 31
Issue: 13
Pages: 107827
•
•
•
•
•
Publication
17182110 | J:126829
First Author: Carter LL
Year: 2007
Journal: J Neuroimmunol
Title: PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.
Volume: 182
Issue: 1-2
Pages: 124-34
•
•
•
•
•
Publication
15749874 | J:97695
First Author: Sandner SE
Year: 2005
Journal: J Immunol
Title: Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo.
Volume: 174
Issue: 6
Pages: 3408-15
•
•
•
•
•
Publication
25113973 | J:218724
First Author: Penaloza-MacMaster P
Year: 2014
Journal: J Exp Med
Title: Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection.
Volume: 211
Issue: 9
Pages: 1905-18
•
•
•
•
•
Publication
36577929 | J:352475
First Author: Kim MJ
Year: 2023
Journal: Nat Immunol
Title: Deletion of PD-1 destabilizes the lineage identity and metabolic fitness of tumor-infiltrating regulatory T cells.
Volume: 24
Issue: 1
Pages: 148-161
•
•
•
•
•
Publication
21873525 | J:179337
First Author: Zelinskyy G
Year: 2011
Journal: J Immunol
Title: Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication.
Volume: 187
Issue: 7
Pages: 3730-7
•
•
•
•
•
Publication
27496729 | J:258882
First Author: Bengsch B
Year: 2016
Journal: Immunity
Title: Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion.
Volume: 45
Issue: 2
Pages: 358-73
•
•
•
•
•
Publication
23853599 | J:213364
First Author: Isogawa M
Year: 2013
Journal: PLoS Pathog
Title: CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion.
Volume: 9
Issue: 7
Pages: e1003490
•
•
•
•
•
Publication
33744709 | J:326724
 
First Author: He X
Year: 2021
Journal: J Neuroimmunol
Title: Programmed death protein 1 is essential for maintaining the anti-inflammatory function of infiltrating regulatory T cells in a murine spinal cord injury model.
Volume: 354
Pages: 577546
•
•
•
•
•
Publication
21884581 | J:182372
 
First Author: Grellier E
Year: 2011
Journal: Mol Cancer
Title: A fiber-modified adenoviral vector interacts with immunoevasion molecules of the B7 family at the surface of murine leukemia cells derived from dormant tumors.
Volume: 10
Pages: 105
•
•
•
•
•
Publication
23417675 | J:263399
First Author: Cheng X
Year: 2013
Journal: J Biol Chem
Title: Structure and interactions of the human programmed cell death 1 receptor.
Volume: 288
Issue: 17
Pages: 11771-85
•
•
•
•
•
Publication
19234176 | J:146254
First Author: Parekh VV
Year: 2009
Journal: J Immunol
Title: PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.
Volume: 182
Issue: 5
Pages: 2816-26
•
•
•
•
•
Publication
19230866 | J:148554
First Author: Bishop KD
Year: 2009
Journal: Cell Immunol
Title: Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.
Volume: 256
Issue: 1-2
Pages: 86-91
•
•
•
•
•
Publication
19454662 | J:148873
First Author: Chikuma S
Year: 2009
Journal: J Immunol
Title: PD-1-mediated suppression of IL-2 production induces CD8+ T cell anergy in vivo.
Volume: 182
Issue: 11
Pages: 6682-9
•
•
•
•
•
Publication
19497561 | J:150136
First Author: Yadav D
Year: 2009
Journal: Cell Immunol
Title: Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.
Volume: 258
Issue: 2
Pages: 161-71
•
•
•
•
•
Publication
21357717 | J:171949
First Author: Gutierrez FR
Year: 2011
Journal: Infect Immun
Title: Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1.
Volume: 79
Issue: 5
Pages: 1873-81
•
•
•
•
•
Publication
24031027 | J:205416
First Author: Belai EB
Year: 2014
Journal: Carcinogenesis
Title: PD-1 blockage delays murine squamous cell carcinoma development.
Volume: 35
Issue: 2
Pages: 424-31
•
•
•
•
•
Publication
29967259 | J:265564
First Author: Tsukamoto H
Year: 2018
Journal: Cancer Res
Title: Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
Volume: 78
Issue: 17
Pages: 5011-5022
•
•
•
•
•
Publication
26048148 | J:330991
First Author: Imai Y
Year: 2015
Journal: J Immunol
Title: Cutting Edge: PD-1 Regulates Imiquimod-Induced Psoriasiform Dermatitis through Inhibition of IL-17A Expression by Innate γδ-Low T Cells.
Volume: 195
Issue: 2
Pages: 421-5
•
•
•
•
•
Publication
35394861 | J:344949
First Author: Policheni AN
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: PD-1 cooperates with AIRE-mediated tolerance to prevent lethal autoimmune disease.
Volume: 119
Issue: 15
Pages: e2120149119
•
•
•
•
•
Publication
21383057 | J:176836
First Author: Wang L
Year: 2011
Journal: J Exp Med
Title: VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.
Volume: 208
Issue: 3
Pages: 577-92
•
•
•
•
•
Publication
18684942 | J:140186
First Author: Lucas JA
Year: 2008
Journal: J Immunol
Title: Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
Volume: 181
Issue: 4
Pages: 2513-21
•
•
•
•
•
Publication
31606264 | J:282315
First Author: Chen Z
Year: 2019
Journal: Immunity
Title: TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision.
Volume: 51
Issue: 5
Pages: 840-855.e5
•
•
•
•
•
Publication
30607385 | J:286028
First Author: Voynova E
Year: 2018
Journal: Immunohorizons
Title: Requirement for CD40/CD40L Interactions for Development of Autoimmunity Differs Depending on Specific Checkpoint and Costimulatory Pathways.
Volume: 2
Issue: 1
Pages: 54-66
•
•
•
•
•
Publication
22915761 | J:191805
First Author: Peng W
Year: 2012
Journal: Cancer Res
Title: PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines.
Volume: 72
Issue: 20
Pages: 5209-18
•
•
•
•
•
Publication
25609381 | J:219708
 
First Author: Khan AR
Year: 2015
Journal: Nat Commun
Title: PD-L1hi B cells are critical regulators of humoral immunity.
Volume: 6
Pages: 5997
•
•
•
•
•
Publication
26392556 | J:227076
First Author: Vomhof-DeKrey EE
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: Cognate interaction with iNKT cells expands IL-10-producing B regulatory cells.
Volume: 112
Issue: 40
Pages: 12474-9
•
•
•
•
•
Publication
21393583 | J:191478
First Author: Bu DX
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
Volume: 31
Issue: 5
Pages: 1100-7
•
•
•
•
•
Publication
22906740 | J:188131
First Author: Doi T
Year: 2012
Journal: Biochem Biophys Res Commun
Title: IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine.
Volume: 425
Issue: 4
Pages: 918-23
•
•
•
•
•
Publication
27294527 | J:237135
First Author: Saha A
Year: 2016
Journal: J Clin Invest
Title: Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
Volume: 126
Issue: 7
Pages: 2642-60
•
•
•
•
•
Publication
24353266 | J:207317
First Author: Fankhauser SC
Year: 2014
Journal: J Immunol
Title: PD-L1 limits the mucosal CD8+ T cell response to Chlamydia trachomatis.
Volume: 192
Issue: 3
Pages: 1079-90
•
•
•
•
•
Publication
23230000 | J:194617
First Author: Frebel H
Year: 2012
Journal: J Exp Med
Title: Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice.
Volume: 209
Issue: 13
Pages: 2485-99
•
•
•
•
•
Publication
24021877 | J:202027
First Author: Mukherjee G
Year: 2013
Journal: Int Immunol
Title: DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.
Volume: 25
Issue: 11
Pages: 651-60
•
•
•
•
•
Publication
18996482 | J:145018
First Author: Kroner A
Year: 2009
Journal: Neurobiol Dis
Title: The co-inhibitory molecule PD-1 modulates disease severity in a model for an inherited, demyelinating neuropathy.
Volume: 33
Issue: 1
Pages: 96-103
•
•
•
•
•
Publication
36385524 | J:340477
First Author: Axelrod ML
Year: 2022
Journal: Nature
Title: T cells specific for α-myosin drive immunotherapy-related myocarditis.
Volume: 611
Issue: 7937
Pages: 818-826
•
•
•
•
•
Publication
28173160 | J:238644
First Author: Groh J
Year: 2016
Journal: Hum Mol Genet
Title: Pathogenic inflammation in the CNS of mice carrying human PLP1 mutations.
Volume: 25
Issue: 21
Pages: 4686-4702
•
•
•
•
•
Publication
19339692 | J:149357
First Author: Yao S
Year: 2009
Journal: Blood
Title: PD-1 on dendritic cells impedes innate immunity against bacterial infection.
Volume: 113
Issue: 23
Pages: 5811-8
•
•
•
•
•
Publication
29337305 | J:323505
First Author: Lin H
Year: 2018
Journal: J Clin Invest
Title: Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression.
Volume: 128
Issue: 2
Pages: 805-815
•
•
•
•
•
Publication
27829150 | J:240975
First Author: Jiang TT
Year: 2016
Journal: Cell Rep
Title: Programmed Death-1 Culls Peripheral Accumulation of High-Affinity Autoreactive CD4 T Cells to Protect against Autoimmunity.
Volume: 17
Issue: 7
Pages: 1783-1794
•
•
•
•
•
Publication
24975127 | J:318803
First Author: Chen X
Year: 2014
Journal: Eur J Immunol
Title: PD-1 regulates extrathymic regulatory T-cell differentiation.
Volume: 44
Issue: 9
Pages: 2603-16
•
•
•
•
•
Publication
28768188 | J:254942
First Author: Okada M
Year: 2017
Journal: Cell Rep
Title: Blockage of Core Fucosylation Reduces Cell-Surface Expression of PD-1 and Promotes Anti-tumor Immune Responses of T Cells.
Volume: 20
Issue: 5
Pages: 1017-1028
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom